Flash Finance

Apollo Hospitals Enterprise LimitedAPOLLOHOSPCorporate

Healthcare Medical Care Facilities Latest results: Mar 2026 14 quarters of data
Consolidated Standalone
₹7,890.00
MCap ₹113,446 Cr · P/E 56.7
Apollo Hospitals Enterprise Limited — Stock analysis & AI research Apollo Hospitals Enterprise Limited — Multibagger AI analysis Apollo Hospitals Enterprise Limited — Seasonality — best & worst months Apollo Hospitals Enterprise Limited — Technical indicators & charts Apollo Hospitals Enterprise Limited — Technical setup — score, trend, support & resistance Apollo Hospitals Enterprise Limited — Live exchange announcements
📋 High ROE Stocks📋 High Profit Growth Stocks📋 Stocks With Strong Quarterly Results📋 Large Cap Stocks List ⚖️ vs Max Healthcare⚖️ vs Aster DM 🏭 Healthcare sector
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹6,606 Cr
Sales · Mar 2026
+18.1% YoY
₹1,011 Cr
Operating Profit · Mar 2026
+31.3% YoY
15.3%
OPM % · Mar 2026
+10.9% YoY
₹551 Cr
Net Profit · Mar 2026
+32.9% YoY
₹36.81
EPS · Mar 2026
+35.8% YoY

📝 Apollo Hospitals Enterprise Limited — results explained

Quarter ended March 2026 (Q4 FY26)

Apollo Hospitals Enterprise Limited reported revenue of ₹6,606 crore for the quarter ended March 2026 (Q4 FY26), up 18.1% from ₹5,592 crore in the same quarter last year, and up 2.0% sequentially over the December 2025 quarter.

Net profit rose 32.9% year-on-year to ₹551 crore, from ₹414 crore. Earnings per share (EPS) came in at ₹36.81.

Operating profit stood at ₹1,011 crore — an operating margin (OPM) of 15.3%, compared with 13.8% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Apollo Hospitals Enterprise Limited posted revenue of ₹25,229 crore, a growth of 15.8% over FY25, with a net profit of ₹2,002 crore (up 33.1% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹25,229 crore with a net profit of ₹2,002 crore.

Valuation snapshot

At the current price of ₹7,890.00, APOLLOHOSP has a market capitalisation of ₹113,446 crore and a trailing P/E of about 56.7.

Within the Medical Care Facilities industry, it is the largest of the 11 companies we track by market value.

Shareholding pattern

As of Sep 2026, promoters held 28.02%, foreign institutional investors (FIIs) 43.18%, domestic institutional investors (DIIs) 22.07%, the government 0.23%, public shareholders 6.49% of Apollo Hospitals Enterprise Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹113,446 Cr
Current Price ?
₹7,890.0
P/E ?
56.66above ind
Industry P/E ?
56.40
P/B ?
11.97
P/S ?
4.50
P/FCF ?
122.64
Enterprise Value ?
₹121,939 Cr
EV/EBITDA ?
32.35
PEG ?
1.67
Earnings Yield ?
2.4%
Dividend Yield ?
0.23%
Profitability & Returns
Sales (TTM) ?
₹25,229 Cr
OPM ?
14.9%
Profit after tax (TTM) ?
₹2,002 Cr
EPS (TTM) ?
₹139.26
ROCE ?
18.0%
ROE ?
21.1%
ROA ?
9.0%
Growth
Sales — latest qtr ?
₹6,606 Cr
PAT — latest qtr ?
₹551 Cr
YoY qtr sales growth ?
18.1%
YoY qtr profit growth ?
32.9%
Sales growth (3y) ?
15%
Sales growth (5y) ?
19%
Profit growth (3y) ?
34%
Profit growth (5y) ?
78%
Financial Health
Debt ?
₹8,493 Cr
Debt to Equity ?
0.90
Interest Coverage ?
6.4
Current Ratio ?
N/A
Ownership
Promoter holding ?
28.02%
Change in promoter holding ?
-1.32%
Pledged percentage ?
N/A
Market
Return 3 months ?
-10.6%
Return 6 months ?
2.5%

🗓️ Quarterly results (14 quarters · ₹ Cr)

same fiscal quarter as Mar bestweakest per row · for costs (interest, NPAs) low is best
Metric Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026 YoY % QoQ %
Sales 4,2644,3024,4184,8474,8514,9445,0865,5895,5275,5925,8426,3046,4776,606 +18.1% +2.0%
Operating Profit 4844885096286146406758167627708529419651,011 +31.3% +4.7%
Other Income 3520342429283744696140555354 -11.6% +2.3%
Interest 10095106111113119116118110115108110113119 +3.7% +5.7%
Depreciation 153159167163167190177184185211215218219224 +6.2% +2.2%
Profit Before Tax 266254270379363368430557536516583675682722 +40.1% +5.9%
Net Profit 162146173249254258316396379414441494516551 +32.9% +6.7%
EPS 10.6810.0511.5916.2017.0617.6521.2326.3425.8927.1030.1033.1934.9436.81 +35.8% +5.4%
OPM % 11.4% 11.3% 11.5% 12.9% 12.7% 13.0% 13.3% 14.6% 13.8% 13.8% 14.6% 14.9% 14.9% 15.3% +10.9% +2.7%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹21,794 Cr ₹25,229 Cr ₹25,229 Cr +15.8%
Operating Profit ₹3,022 Cr ₹3,769 Cr ₹3,769 Cr +24.7%
OPM % 13.87% 14.94% 14.94% +7.7%
NPM % 6.90% 7.94% 7.94% +15.1%
Other Income ₹211 Cr ₹202 Cr ₹202 Cr -4.5%
Depreciation ₹758 Cr ₹876 Cr ₹876 Cr +15.5%
Interest ₹459 Cr ₹450 Cr ₹450 Cr -2.0%
EBIT ₹2,264 Cr ₹2,894 Cr ₹2,894 Cr +27.8%
PBT ₹2,039 Cr ₹2,661 Cr ₹2,661 Cr +30.5%
Tax ₹377 Cr ₹488 Cr ₹488 Cr +29.4%
Net Profit ₹1,505 Cr ₹2,002 Cr ₹2,002 Cr +33.1%
EPS ₹100.56 ₹135.04 ₹135.04 +34.3%
Material Cost ₹8,394 Cr ₹9,707 Cr ₹9,707 Cr +15.6%
Employee Cost ₹2,083 Cr ₹2,228 Cr ₹2,228 Cr +7.0%
Extraordinary Items — ₹-4 Cr ₹-4 Cr —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 72727272 +0.0%
Reserves 6,1266,8648,1409,408 +15.6%
Borrowings 4,3325,3337,8648,493 +8.0%
Other Liabilities 3,8864,4744,5684,224 -7.5%
Total Liabilities 14,41616,74220,64422,197 +7.5%
Fixed Assets 8,5209,66410,98812,312 +12.0%
CWIP 610873921992 +7.7%
Investments 5749862,4872,179 -12.4%
Other Assets 4,7125,2196,2486,714 +7.5%
Total Assets 14,41616,74220,64422,197 +7.5%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 1,3771,9202,1362,856 +33.7%
Cash from Investing Activity -857-1,537-3,381-2,148 +36.5%
Cash from Financing Activity -633-3111,317-478 -136.3%
Net Cash Flow -1137273230 +215.1%
Free Cash Flow 252785439925 +110.7%
CFO/OP 85%100%86%92% +7.0%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 49485150 -2.0%
Inventory Days 17171615 -6.2%
Days Payable 82887263 -12.5%
Cash Conversion Cycle -16-23-63 +150.0%
Working Capital Days -1-19-6-10 -66.7%
ROCE % 14%15%17%18% +5.9%

👥 Shareholding (latest 6 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026 % Chg
Promoters 29.34%28.02%28.02%28.02%28.02%28.02% +0.0%
FIIs 43.49%44.20%43.54%42.62%41.50%43.18% +4.0%
DIIs 21.34%21.12%21.50%22.76%23.72%22.07% -7.0%
Government 0.23%0.23%0.23%0.23%0.23%0.23% +0.0%
Public 5.61%6.43%6.71%6.39%6.54%6.49% -0.8%
No. of Shareholders 1,41,0071,60,5561,78,6481,74,6101,74,2811,72,863 -0.8%

⚖️ Peer comparison

Industry: Medical Care Facilities · 11 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 APOLLOHOSP Apollo Hospitals ₹7,988.50 114,862 59.2 25,229 2,002 14.9% 7.9% 15.8% 33.1% 18.1% 32.9%
2 MAXHEALTH Max Healthcare ₹1,037.70 101,000 69.2 8,712 1,457 26.6% 16.7% 19.1% 34.1% 16.7% 4.9%
3 MANIPALHOS Manipal Health ₹710.85 93,504 — — — — — — — 28.2% -8.3%
4 FORTIS Fortis Healthcare ₹887.80 67,025 64.3 9,128 1,064 22.8% 11.7% 17.3% 31.4% 17.8% 44.1%
5 ASTERDM Aster DM ₹763.50 66,552 198.5 4,876 363 19.0% 7.5% 44.2% 138.8% 21.6% -68.9%
6 MEDANTA Global Health ₹1,445.60 38,846 69.8 4,683 553 20.9% 11.8% 19.4% 15.1% 26.5% -1.1%
7 NH Narayana Hrudayalaya ₹1,869.90 37,978 46.6 9,073 817 19.3% 9.0% 41.4% 1.9% 78.0% 5.4%
8 KIMS Krishna Institute ₹767.50 30,711 148.9 4,214 194 19.8% 4.6% 28.7% -41.5% 35.3% -56.0%
9 RAINBOW Rainbow Children's ₹1,450.00 14,710 51.6 1,820 290 31.6% 15.9% 12.4% 15.2% 33.2% 16.2%
10 GAUDIUMIVF Gaudium IVF ₹116.42 847 36.4 106 23 32.9% 21.8% — — 9.1% -42.2%
11 MOMSBELIEF Rays of Belief ₹223.00 466 — — — — — — — 136.4% 616.1%
❓ Frequently asked questions
What was Apollo Hospitals Enterprise Limited's revenue in Q4 FY26?
Apollo Hospitals Enterprise Limited reported revenue of ₹6,606 crore for the quarter ended March 2026 (Q4 FY26), up 18.1% from ₹5,592 crore in the same quarter last year, and up 2.0% sequentially over the December 2025 quarter.
What was Apollo Hospitals Enterprise Limited's net profit in Q4 FY26?
Net profit rose 32.9% year-on-year to ₹551 crore, from ₹414 crore. Earnings per share (EPS) came in at ₹36.81.
What is APOLLOHOSP's market capitalisation and P/E ratio?
At the current price of ₹7,890.00, APOLLOHOSP has a market capitalisation of ₹113,446 crore and a trailing P/E of about 56.7.
Who owns Apollo Hospitals Enterprise Limited? (shareholding pattern)
As of Sep 2026, promoters held 28.02%, foreign institutional investors (FIIs) 43.18%, domestic institutional investors (DIIs) 22.07%, the government 0.23%, public shareholders 6.49% of Apollo Hospitals Enterprise Limited.
TTM ends 2026-03-31. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI